Abstract
Nebulization therapy as a topical treatment for sinusitis is one of the most widely used therapies because of its safety and convenience and due to its advantages as a painless therapy and its ability to simultaneously spread an agent to plural paranasal sinuses. We conducted a randomized controlled study on the efficacy of cefmenoxime (CMX) nebulization therapy vs oral resolutional enzyme therapy, and report interesting results on efficacy. Subjects were 18 CMX nebulization patients and 15 oral resolutional enzyme therapy patients was examined for therapeutic efficacy. Clinical efficacy was 77.8% in CMX nebulization and 26.7% in oral resolutional enzyme therapy. We concluded that CMX nebulization has at least a statistical advantage over oral resolutional enzyme therapy.
